A Secret Weapon For "3
These trials confirmed clinically major pharmacokinetic interactions [seven] characterised by a minimize within the clearance with the anticancer drug and hence enhanced exposure. The interpretation of subsequent stage II and III clinical trials was challenging as it was impossible to administer the identical dose of chemotherapy from the existence